These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 7509305

  • 1. [Finasteride (Proscar) for benign prostatic hypertrophy].
    Matzkin H, Chen J, Braf Z.
    Harefuah; 1993 Dec 15; 125(12):453-6, 496. PubMed ID: 7509305
    [Abstract] [Full Text] [Related]

  • 2. [The treatment of patients with benign prostatic hyperplasia with Proscar MSD (finasteride)].
    Stepanov VN, Teodorovich OV, Seregin AV, Kadyrov ZA.
    Urol Nefrol (Mosk); 1995 Dec 15; (5):28-30. PubMed ID: 8571480
    [Abstract] [Full Text] [Related]

  • 3. 5alpha-reductase inhibitors/finasteride.
    Stoner E.
    Prostate Suppl; 1996 Dec 15; 6():82-7. PubMed ID: 8630236
    [Abstract] [Full Text] [Related]

  • 4. [The long-term treatment of patients with benign prostatic hyperplasia using Proscar].
    Lopatkin NA, Roilans PJ, Stoner E.
    Urol Nefrol (Mosk); 1996 Dec 15; (1):2-4. PubMed ID: 8659035
    [Abstract] [Full Text] [Related]

  • 5. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
    Tkachuk VN, Al'-Shukri SKh, Kornienko VI, Kuz'min IV.
    Urol Nefrol (Mosk); 1998 Dec 15; (4):37-9. PubMed ID: 9727320
    [Abstract] [Full Text] [Related]

  • 6. Finasteride in the treatment of benign prostatic hyperplasia.
    Ekman P, Andersen JT, Wolf H.
    Acta Urol Belg; 1996 Mar 15; 64(1):IX-XII. PubMed ID: 8659328
    [Abstract] [Full Text] [Related]

  • 7. Effect of long-term administration of finasteride (MK-906), an inhibitor of 5 alpha-reductase, in patients with benign prostatic hyperplasia.
    Yoshida O, Oishi K, Okada Y, Mizutani Y, Itokawa Y, Tomoyoshi T, Okada K, Komatz Y, Matsuda T, Takeuchi H.
    Hinyokika Kiyo; 1996 Apr 15; 42(4):323-31. PubMed ID: 8693970
    [Abstract] [Full Text] [Related]

  • 8. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
    Pushkar' DIu, Kosko DV, Loran OB, Kan IaD, Sapozhnikov IM, Tevlin KP.
    Urol Nefrol (Mosk); 1995 Apr 15; (4):32-5. PubMed ID: 7571199
    [Abstract] [Full Text] [Related]

  • 9. One-year experience in the treatment of benign prostatic hyperplasia with finasteride. The MK-906 (Finasteride) Study Group.
    J Androl; 1991 Apr 15; 12(6):372-5. PubMed ID: 1722792
    [Abstract] [Full Text] [Related]

  • 10. Current treatment of BPH.
    Roylance P, Gibelin B, Espié J.
    Biomed Pharmacother; 1995 Apr 15; 49(7-8):332-8. PubMed ID: 8562858
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic effect of harnal and proscar in treating benign prostatic hyperplasia].
    Tang ZY, Peng KL, Ding J, Zu XB, Qi L.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec 15; 30(6):708-10. PubMed ID: 16708816
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of men on finasteride.
    Gormley GJ.
    Semin Urol Oncol; 1996 Aug 15; 14(3):139-44. PubMed ID: 8865475
    [Abstract] [Full Text] [Related]

  • 13. Finasteride for benign prostatic hyperplasia.
    Hasinski S, Miller JL, Rose LI.
    Am Fam Physician; 1992 Nov 15; 46(5):1511-4. PubMed ID: 1279965
    [Abstract] [Full Text] [Related]

  • 14. [New prospective therapy for benign prostatic hyperplasia with finasteride].
    Miano L, Manieri C, Paradiso Galatioto G, Vicentini C.
    Riv Eur Sci Med Farmacol; 1993 Nov 15; 15(2):111-9. PubMed ID: 7513437
    [Abstract] [Full Text] [Related]

  • 15. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
    Monti S, Sciarra F, Adamo MV, Toscano V, Trotta MC, Martini C, Lanzara S, Silverio FD.
    J Androl; 1997 Nov 15; 18(5):488-94. PubMed ID: 9349746
    [Abstract] [Full Text] [Related]

  • 16. [Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume].
    Granados Loarca EA.
    Arch Esp Urol; 1999 Apr 15; 52(3):201-8. PubMed ID: 10371735
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of benign prostatic hyperplasia with Proscar (finasteride). Results of a 10-year Scandinavian study].
    Tveter KJ, Beisland HO, Andersen JT, Wolf H, Ekman P, Johansson JE, Kontturi M, Lehtonen T.
    Tidsskr Nor Laegeforen; 1996 Nov 10; 116(27):3226-30. PubMed ID: 9011975
    [Abstract] [Full Text] [Related]

  • 18. [Benign prostatic hyperplasia--its treatment with Proscar].
    Panchev P, Neĭkov K, Simeonov P.
    Khirurgiia (Sofiia); 1996 Nov 10; 49(1):15-8. PubMed ID: 8975081
    [Abstract] [Full Text] [Related]

  • 19. An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    McDonald H, Hux M, Brisson M, Bernard L, Nickel JC.
    Can J Urol; 2004 Aug 10; 11(4):2327-40. PubMed ID: 15380054
    [Abstract] [Full Text] [Related]

  • 20. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK, Ross M, Tate R, Chisholm GD.
    Clin Endocrinol (Oxf); 1997 Feb 10; 46(2):137-44. PubMed ID: 9135694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.